产品中心 药物靶点和Fc受体 药物靶点

所有图片(1/4)

ErbB3/Her3 His Tag Protein, Human

ErbB3,Her3,FERLK,LCCS2,VSCN1

价格 1,350.00 供应商现货 : 3-5个工作日
货号 UA016070
规格
数量
收藏 分享

产品介绍 评论(0)

产品规格
  • 物种

    Human
  • 分子别名

    ErbB3, Her3, FERLK, LCCS2, VSCN1
  • Accession

    P21860
  • 表达序列

    Ser20-Thr643 with His Tag at C-terminal

  • 表达宿主

    HEK293
  • 分子量

    100-130kDa (Reducing)
  • 纯度

    >95% by SDS-PAGE & HPLC
  • 活性

    1. Immobilized ErbB3 / Her3 His Tag Protein, Human (Cat. No.UA016070) at 2.0μg/mL (100μL/well) can bind Anti-Human HER3 Monoclonal Antibody (Patritumab) with EC50 of 0.08-0.16ng/mL. 2. Immobilized ErbB3 / Her3 His Tag Protein, Human (Cat. No. UA016070) at 2.0μg/mL (100μL/well) can bind Human NRG1 Beta 1 Protein, Fc Tag, premium grade with EC50 of 1.90-2.40 ng/mL.
  • 标记

    Unconjugated
  • 性状

    Lyophilized Powder
  • 缓冲体系

    PBS, pH7.4, 5% trehalose

  • 溶解方法

    Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.
  • 储存条件

    · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
    · 3 months, -20 to -80℃ under sterile conditions after reconstitution.
    · 1 week, 2 to 8℃ under sterile conditions after reconstitution.
    · Please avoid repeated freeze-thaw cycles.

  • 文献引用

    1. Ma, J., et al. (2026). HER3 beyond the canonical paradigm: a versatile signaling hub in oncogenesis and therapeutic resistance. Journal of Translational Medicine, 24(1), 123.
    2. Wang, Y., & Zhang, X. (2024). HER3: Updates and current biology function, targeted therapy and pathologic detecting methods. Life Sciences, 357, 123087.
    3. Kiavue, N., et al. (2020). ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics. Oncogene, 39(3), 487-502.

背景介绍
  • Human Epidermal Growth Factor Receptor 3 (HER3/ErbB3) is a distinctive member of the epidermal growth factor receptor (EGFR/ErbB) family, which plays a central role in cell proliferation, differentiation, migration, and survival. Its most prominent feature is that its intracellular kinase domain exhibits extremely low, if not absent, catalytic activity compared to other family members (EGFR, HER2, HER4). Consequently, HER3 cannot signal alone and must heterodimerize with other active family members (primarily HER2) to be activated and initiate downstream signaling pathways.

    Structurally, HER3, like other ErbB family members, consists of an extracellular ligand-binding domain, a single transmembrane helix, and an intracellular domain containing the kinase domain. Its extracellular domain specifically binds to ligands such as Neuregulin (NRG), triggering a conformational change that exposes its dimerization arm, enabling it to bind to EGFR or HER2.

  • 电泳

    • 2μg (R: reducing condition, N: non-reducing condition).

  • 体积排阻色谱(SEC-HPLC)

    • The purity of ErbB3/Her3 His Tag Protein, Human is more than 95% determined by SEC-HPLC.

  • ELISA

    • Immobilized ErbB3 / Her3 His Tag Protein, Human (Cat. No.UA016070) at 2.0μg/mL (100μL/well) can bind Anti-Human HER3 Monoclonal Antibody (Patritumab) with EC50 of 0.08-0.16ng/mL.

    • Immobilized ErbB3 / Her3 His Tag Protein, Human (Cat. No. UA016070) at 2.0μg/mL (100μL/well) can bind Human NRG1 Beta 1 Protein, Fc Tag, premium grade with EC50 of 1.90-2.40 ng/mL.

评论(0)